The public-private partnership granted Emergent $163 million over eight years to assist in the development of countermeasures for health, nuclear and radiological epidemics. Department of Health and Human Services as one of the three Centers for Innovation in Advanced Development and Manufacturing. In June 2012, Emergent, along with Novartis and the Texas A&M University System was selected by the U.S. Mergers, acquisitions and joint ventures ![]() Įmergent became a publicly traded company in 2006, with its stock trading on the New York Stock Exchange under the symbol EBS. ![]() After the 2001 anthrax attacks that caused the deaths of five Americans and made 17 others ill, Bioport began providing its anthrax vaccine to US biodefense agencies. In 2000, operating as Bioport, the company was the subject of Congressional hearings and FDA action (official action indicated (OAI) and voluntary action indicated (VAI)). BioPort purchased the facility and the rights to manufacture the vaccine for the U.S. At the time, the Michigan Department of Public Health, though its Michigan Biologics Products Institute, owned an anthrax vaccine manufacturing facility in Lansing, Michigan. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.ĭuring the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded.Ĭompany history Early history Įmergent BioSolutions was founded on September 5, 1998, by Fuad El-Hibri, under the name BioPort, which had formerly operated as a state-owned entity named Michigan Biological Products Institute and was privatized as Emergent BioSolutions in 2004. Food and Drug Administration (FDA) and Narcan ( naloxone) for the emergency treatment of opioid overdose. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.Īmong the company's products are the controversial BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |